Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance treatment with Revlimid after autologous stem cell transplantation in patients under 65 years with multiple myeloma
2005-001554-24Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Hematologic safety monitoring and dose adjustment. Started Mar 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-001554-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001554-24.